Goldman flags biopharma as China’s ageing winners, carmakers and hardware face headwinds
A demographic squeeze in China could tilt investment and demand toward pharmaceuticals, while autos and tech hardware get tougher.
By Yousef Al-Zahrani·· 3 min
1 briefing · “biotechnology”
A demographic squeeze in China could tilt investment and demand toward pharmaceuticals, while autos and tech hardware get tougher.